Cancer News and Research

Latest Cancer News and Research

Treg therapy ensures success of hematopoietic stem cell transplantation, without triggering GVHD

For blood cancer patients at high risk of relapse, hematopoietic stem cell transplantation (HSCT), the transplantation of blood-forming stem cells, is one of best options for treatment and a potential cure. Unfortunately, the most common complication of HSCT is graft-versus-host disease (GVHD), a serious and often deadly post-transplant complication that occurs when the newly transplanted donor cells recognize the recipient's own cells as foreign and react by attacking the cells in the patient's body.

4 Feb 2011

Cell signaling hormone boosts immune response to clear HIV-like infection

Australian scientists have successfully cleared a HIV-like infection from mice by boosting the function of cells vital to the immune response.

4 Feb 2011

New study provides insight into mechanism behind breast cancer mutation

A new study sheds light on why individuals who inherit a particular family of mutations have a high risk of developing a very aggressive form of breast cancer. The research, published by Cell Press on February 4th in the journal Cell Stem Cell, shows that breast tissue cells from these individuals make abnormal cell-fate decisions even before cancer develops and provides exciting new insights into the mechanisms behind one of the most lethal types of breast cancer.

4 Feb 2011

MedAssurant, UNC to assess relationship between insulin and cancer development

MedAssurant, a leading provider of data-driven healthcare solutions, today announced the initiation of a joint study with the University of North Carolina to assess the relationship between the use of long-acting insulin to treat diabetes and the development of cancer.

4 Feb 2011

U.S. Patent Office issues Notice of Allowance to Antigen Express AE37 cancer vaccine

Generex Biotechnology Corporation, together with its wholly-owned immunotherapeutic vaccines subsidiary, Antigen Express, announced today that Antigen Express has received a Notice of Allowance from the United States Patent Office relating to an application making augmentative pharmaceutical composition claims for the Antigen Express AE37 immunotherapeutic cancer vaccine.

4 Feb 2011

More careful regulation of FDA's Humanitarian Device Exemption in psychiatric patients needed

Warning that patients could be at risk, an interdisciplinary group of multinational investigators is calling on the U.S. Congress and federal regulators to tighten a law that permits use of brain devices to treat rare neuropsychiatric disorders without supporting clinical trials or stringent patient oversight.

4 Feb 2011

Cardiac team implants pulmonary valve in children without open-heart surgery

The pediatric cardiac team at Oregon Health & Science University Doernbecher Children's Hospital is the first in the region and one of a handful in the nation to implant a pulmonary heart valve without open-heart surgery.

4 Feb 2011

Women's risk of getting breast cancer increases from one in nine to one in eight

The lifetime risk of getting breast cancer has risen from one woman in nine to one in eight - according to Cancer Research UK.

4 Feb 2011

Scientists unravel mystery about how new tumors in individuals with breast cancer take root

In a discovery that may lead to a new treatment for breast cancer that has spread to the bone, a Princeton University research team has unraveled a mystery about how these tumors take root.

4 Feb 2011

Immune protein exacerbates skin cancer due to sun exposure: Study

An unexpected immune protein exacerbates cancer due to sun exposure, report researchers in the January 27th issue of Nature. The study suggests that drugs blocking the protein might halt tumor growth in skin cancer patients.

3 Feb 2011

FDA approves Hospira's topotecan for SCLC

Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced U.S. Food and Drug Administration (FDA) approval of Topotecan Injection, the first solution formulation of the oncology drug approved in the United States.

3 Feb 2011

FIND, Cepheid collaborate to develop rapid molecular test for measurement of HIV viral load

Cepheid and FIND today announced a new collaboration to accelerate the development of a rapid molecular test for the measurement of human immunodeficiency virus viral load.

3 Feb 2011

Philanthropist awards Mayo Clinic $100 million to establish Proton Beam Therapy Program

Mayo Clinic today announced long-time patient and philanthropist Richard O. Jacobson has given a $100 million gift to help establish the multi-site Mayo Clinic Proton Beam Therapy Program. This is the largest outright gift in the clinic's history, as well as the largest gift Mr. Jacobson has made to any single institution.

3 Feb 2011

ZIOPHARM prices underwritten public offering of 9,600,000 shares of common stock

ZIOPHARM Oncology, today announced the pricing of an underwritten public offering of 9,600,000 shares of its common stock at a price to the public of $5.75 per share.

3 Feb 2011

Cancer Research UK launches 'Musicommercial' to help beat cancer

The first ever 'Musicommercial' is unveiled today to launch this year's Tesco and Cancer Research UK's Race for Life - the UK's largest women-only fundraising event series.

3 Feb 2011

Genmab reports GBP 9 million net sales for Arzerra in fourth quarter 2010

Genmab A/S announced today that the net sales for Arzerra® (ofatumumab) during the fourth quarter of 2010 were GBP 9 million (approximately DKK 77 million).

3 Feb 2011

Surrogate questions imaging can answer about cancer

A Professor who is investigating how modern body imaging techniques can be adapted to answer new questions - such as the anti-cancer properties of fish oils and green tea, or establishing cause of death in forensic investigation - is to give a free public lecture at the University of Leicester.

3 Feb 2011

Blue Cross and Blue Shield of Minnesota, American Cancer Society receive CEO Cancer Gold Standard accreditation

Blue Cross and Blue Shield of Minnesota and the American Cancer Society - High Plains Division have received CEO Cancer Gold Standard™ accreditation, recognizing the commitment of these organizations to reducing the risk of cancer for employees and their families by promoting healthy lifestyle choices, encouraging early detection through cancer screenings, and ensuring access to quality treatment.

3 Feb 2011

AVEO receives USAN, WHO generic name approval for ficlatuzumab

AVEO Pharmaceuticals, Inc. today announced that the United States Adopted Names (USAN) Council, in consultation with the World Health Organization (WHO) International Nonproprietary Names Expert Committee, has approved the use of the nonproprietary generic name "ficlatuzumab" (pronounced fye" kla tue' zue mab) for AV-299, a potent, functional anti-HGF/c-MET antibody internally discovered at AVEO.

3 Feb 2011

PanCare Childhood and Adolescent Cancer Survivor Care and Follow-up Studies to kick off in Lund, Sweden

By learning more about these late effects of treatment, the health care services can, on the one hand, improve and reduce the intensity of the treatment, and, on the other hand, find appropriate ways to care for those suffering from side-effects of the treatment in adolescence and adulthood.

3 Feb 2011

Cancer News and Research

Latest Cancer News and Research

Treg therapy ensures success of hematopoietic stem cell transplantation, without triggering GVHD

Cell signaling hormone boosts immune response to clear HIV-like infection

New study provides insight into mechanism behind breast cancer mutation

MedAssurant, UNC to assess relationship between insulin and cancer development

U.S. Patent Office issues Notice of Allowance to Antigen Express AE37 cancer vaccine

More careful regulation of FDA's Humanitarian Device Exemption in psychiatric patients needed

Cardiac team implants pulmonary valve in children without open-heart surgery

Women's risk of getting breast cancer increases from one in nine to one in eight

Scientists unravel mystery about how new tumors in individuals with breast cancer take root

Immune protein exacerbates skin cancer due to sun exposure: Study

FDA approves Hospira's topotecan for SCLC

FIND, Cepheid collaborate to develop rapid molecular test for measurement of HIV viral load

Philanthropist awards Mayo Clinic $100 million to establish Proton Beam Therapy Program

ZIOPHARM prices underwritten public offering of 9,600,000 shares of common stock

Cancer Research UK launches 'Musicommercial' to help beat cancer

Genmab reports GBP 9 million net sales for Arzerra in fourth quarter 2010

Surrogate questions imaging can answer about cancer

Blue Cross and Blue Shield of Minnesota, American Cancer Society receive CEO Cancer Gold Standard accreditation

AVEO receives USAN, WHO generic name approval for ficlatuzumab

PanCare Childhood and Adolescent Cancer Survivor Care and Follow-up Studies to kick off in Lund, Sweden

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in